| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Baloxavir | Baloxavir Impurity 1 | VE0012551 | View |
| Baloxavir | Baloxavir Impurity 1-D5 | DVE00182 | View |
| Baloxavir | Baloxavir Impurity 2 | VE0012556 | View CAS 2571566-81-7 |
Baloxavir Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Baloxavir | Baloxavir Impurity 1 | VE0012551 | View |
| Baloxavir | Baloxavir Impurity 1-D5 | DVE00182 | View |
| Baloxavir | Baloxavir Impurity 2 | VE0012556 | View CAS 2571566-81-7 |
[rfq_list]
| Catalogue No. | VE0012556 |
| CAS No. | 2571566-81-7 |
| Molecular Formula | C24H19F2N3O4S |
| Molecular Weight | 483.49 g/mol |
| Parent drug | Baloxavir |
| IUPAC Name | (S)-12-((S)-7, 8-difluoro-6, 11-dihydrodibenzo[b, e]thiepin-11-yl)-7-hydroxy-3, 4, 12, 12a-tetrahydro-1H-[1, 4]oxazino[3, 4-c]pyrido[2, 1-f][1, 2, 4]triazine-6, 8-dione |
| Smiles | – |
| References | – |
| Status | In-stock |
| ListName | Baloxavir Impurity 2 |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
